Healthcare >> CEO Interviews >> August 28, 2013

Interview with the Chairman and CEO: Astex Pharmaceuticals, Inc. (ASTX)

James S.J. Manuso, Ph.D., MBA, currently serves as Chairman and Chief Executive Officer of Astex Pharmaceuticals, Inc. He served as President, Chairman and Chief Executive Officer from January 2004 to July 2011, as CEO-elect from September 2003 to December 2003 and as a Director since February 2001. He is Co-Founder and immediate past President and Chief Executive Officer of Galenica Pharmaceuticals, Inc. Dr. Manuso cofounded and was General Partner of PrimeTech Partners, a biotechnology venture management partnership, from 1998 to 2002, and Co-Founder and Managing General Partner of The Channel Group LLC, an international life sciences corporate advisory firm. He was also President of Manuso, Alexander & Associates, Inc., management consultants and financial advisers to pharmaceutical and biotechnology companies. Dr. Manuso was a Vice President and Director of Health Care Planning and Development for The Equitable Companies, now Group AXA. He currently serves on the boards of Novelos Therapeutics, Inc., and privately held KineMed, Inc. Dr. Manuso earned a B.A. with honors in economics and chemistry from New York University, a Ph.D. in experimental psychophysiology from the Graduate Faculty of The New School University, a certificate in health systems management from Harvard Business School and an Executive MBA from Columbia Business School. Dr. Manuso is the author of over 30 chapters, articles and books on topics including health care cost containment and biotechnology company management. Profile
TWST: Let's begin with a brief overview of Astex Pharmaceuticals, including the company's history, products, services and research. 

Dr. Manuso: Our company was founded